VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 493 filers reported holding VANECK VECTORS ETF TR in Q3 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $462,000 | -91.4% | 20,059 | -89.0% | 0.36% | -88.3% |
| Q4 2019 | $5,352,000 | +4.9% | 182,785 | -4.3% | 3.04% | -8.3% |
| Q3 2019 | $5,104,000 | +4.6% | 191,081 | +0.1% | 3.32% | +6.0% |
| Q2 2019 | $4,878,000 | +18.2% | 190,864 | +3.7% | 3.13% | +4.9% |
| Q1 2019 | $4,126,000 | +1543.8% | 184,024 | +1258.1% | 2.99% | +1677.4% |
| Q3 2018 | $251,000 | +325.4% | 13,550 | +411.3% | 0.17% | +320.0% |
| Q2 2018 | $59,000 | -11.9% | 2,650 | -13.1% | 0.04% | -2.4% |
| Q1 2018 | $67,000 | +63.4% | 3,050 | +74.3% | 0.04% | +57.7% |
| Q4 2017 | $41,000 | -91.5% | 1,750 | -91.6% | 0.03% | -92.0% |
| Q3 2017 | $481,000 | -29.6% | 20,950 | -32.3% | 0.33% | -31.9% |
| Q2 2017 | $683,000 | -1.4% | 30,950 | +1.8% | 0.48% | -3.8% |
| Q1 2017 | $693,000 | +65.0% | 30,400 | +51.2% | 0.50% | +65.4% |
| Q4 2016 | $420,000 | – | 20,100 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |